Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. - Wikidata - awgldk - TriplyDB

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

http://www.wikidata.org/entity/Q33949664

about

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)ADHD in Children Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity Disorder Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges Changes in behavior as side effects in methylphenidate treatment: review of the literature A review of long-acting medications for ADHD in Canada Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents Premarket safety and efficacy studies for ADHD medications in children ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants Concordance between parent and physician medication histories for children and adolescents with attention-deficit/hyperactivity disorder.A dose-ranging study of behavioral and pharmacological treatment in social settings for children with ADHD Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.ADHD in children and adolescents.Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder.Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short Form.New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.Clinical case rounds in child and adolescent psychiatry: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series.Preferences related to attention-deficit/hyperactivity disorder and its treatment.Effect of methylphenidate on sleep parameters in children with ADHD.A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.Reinforcement enhances vigilance among children with ADHD: comparisons to typically developing children and to the effects of methylphenidate.Methylphenidate transdermal system: a multisite, open-label study of dermal reactions in pediatric patients diagnosed with ADHD.Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis.Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG.An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety.What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale.Effects of behavioral and pharmacological therapies on peer reinforcement of deviancy in children with ADHD-only, ADHD and conduct problems, and controls Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder.Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta Managing attention deficit/hyperactivity disorder: unmet needs and future directions Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate

P2860

Q22061981-A08C5054-CDE7-433F-8C61-BCC7D7E7EA9E Q22305481-B6D673DE-4C49-4019-8EFD-B800DC4A47D4 Q26822392-F56AAF99-6B85-41EC-865A-D0B9EFD39247 Q28078623-686281B2-182C-416E-BD30-14D544DA4EC7 Q28263326-8862F899-B8B3-4CBD-8EA0-B70E353C5A85 Q28282770-68A4E552-8FDC-45DE-8375-874EA4AD2006 Q28540563-417BFDFD-57EA-4ADE-B9E5-30E1304CDE10 Q30498399-81516114-447B-4DE4-BB5D-ECB3AD495BB7 Q33588902-8DD1338B-E040-4A0E-AD1F-853547437B45 Q33746664-F6D795B6-D922-4135-A1DB-11440B0440E3 Q33782808-E484A235-0FF2-434D-B48F-520ADAEE14E1 Q33875623-061A62EA-7639-4540-BBE5-EAA9280A4181 Q33900589-2996EFB4-3BBD-4773-82A8-036645C5D694 Q33947402-147F7E96-98D9-46DF-A055-D28E9EDA17CD Q33987476-3981E7FC-F4E4-44FF-AAFE-DD62F1562A74 Q34011677-131BD79C-A97F-48F4-85A9-C72BE8D09D25 Q34012703-DECDACBD-7AEE-4FF9-8085-FC07C3C1F1FD Q34072167-5ACCBC46-2C52-47ED-9543-7B13A2F74EA8 Q34131298-9315AFAE-9EBC-4313-86E7-03A7B7BAC501 Q34205490-DF42D93B-C294-497C-BA1A-4B236DD07FB5 Q34371046-8479187C-8158-4B8A-A053-CAADA75CB2B0 Q34468658-5F2E6C30-050D-43CD-ADEB-BC76A6F1CB7E Q34509168-C7BBC4D3-875B-4032-9B9E-A25AD43F1FF0 Q34554897-B8821231-5ABD-4D24-BBE7-E4CF911A0C3A Q34646622-26426A0B-0E47-4B58-AC72-C997FCCF115D Q34719188-BA466644-B8BA-4BE4-AFC9-86A688FD04B4 Q34725704-A93221C0-F981-49EC-980E-62125B04D772 Q34743102-8FD0D2DF-77ED-48EA-8EEF-9573D00E4194 Q34832003-3AB18FBC-5F63-422A-A03F-4E94EBAB961F Q35056233-7A2F4E5E-3C70-4639-9D65-20CC1A17DDA7 Q35206892-0816D4F3-7FF1-4523-A0B4-C994DEBBB261 Q35233563-8F5873BA-986D-43D6-B551-287E5D28011D Q35233590-0A736440-889F-449E-8C85-F51C97ABE5F4 Q35235902-41161ED9-425F-4AD3-B706-5F496240A9B7 Q35477867-0373007D-5CEC-4A3F-9973-A74F919CA89B Q35483556-89573E9F-71BA-4C27-BF46-53379C04AEDA Q35496373-9C16D10F-612F-4D3D-B59B-B22E8D0F23F8 Q35575707-4738148D-C09A-4BAE-9ECA-E039333B9880 Q35576553-AB71B599-C51C-42EF-8163-BF95B11B14C9 Q35579008-B1C0DD77-796A-43F5-90CE-CFB37CDEDE00

P2860

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

http://www.wikidata.org/entity/Q33949664

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Once-a-day Concerta methylphen ...... boratory and natural settings.

@ast

Once-a-day Concerta methylphen ...... boratory and natural settings.

@en

type

label

Once-a-day Concerta methylphen ...... boratory and natural settings.

@ast

Once-a-day Concerta methylphen ...... boratory and natural settings.

@en

prefLabel

Once-a-day Concerta methylphen ...... boratory and natural settings.

@ast

Once-a-day Concerta methylphen ...... boratory and natural settings.

@en

P1433

Q33949664-75232354-8181-4CA7-8283-A5CBA91750DB

P1476

Q33949664-42A3B155-3DF9-4081-83A7-B2BAB0EB846B

P2093

Q33949664-1602EDF3-9992-4825-B9B3-ABF9BE6D2BFD

Q33949664-20300642-55B7-414E-81EE-25CC7472CF4F

Q33949664-300456AE-30EC-4B3E-B4A2-25E525E07A70

Q33949664-4816D196-8004-435E-8C60-8F7F9DACBCDE

Q33949664-4E7B5866-F65F-4C30-A322-25174BABFC48

Q33949664-6BA36A2A-09E2-4D54-ADB7-621E9F8D84F3

Q33949664-6E724537-86D9-4DA7-ACE1-5A0AAAB863F2

Q33949664-6F51DCEA-F230-4DF5-9125-31E4CE31F705

Q33949664-791AD9C8-B9CC-4A62-8027-68E0FB847E5A

Q33949664-81B4D976-2A31-4D62-8518-56F58FC39EB9

P304

Q33949664-552996B0-6DEB-432B-85CA-C965AD9AA73E

P31

Q33949664-0E4BC2EA-BBB1-41E3-A3CD-C8AFE383A93F

P356

Q33949664-64372F09-75B3-4331-AD5A-6CC70EA96113

P407

Q33949664-B95463A9-2692-4BA7-A6D8-A06EB7EB94E9

P433

Q33949664-24EBFCD5-8135-4484-9734-6A39B1FA777C

P478

Q33949664-A3DCC9E6-0209-48A4-80F3-D16D73B365A9

P577

Q33949664-792147EF-47EE-4007-946E-968331316C30

P5875

Q33949664-4634F096-F65D-4B98-A728-563E245FB21A

P698

Q33949664-F39E8630-912A-49C9-9071-204671A7ABC3

P356

PEDS.107.6.E105

P1433

P1476

Once-a-day Concerta methylphen ...... boratory and natural settings.

@en

P2093

Burrows-Maclean L

http://www.w3.org/2001/XMLSchema#string

Chronis AM

http://www.w3.org/2001/XMLSchema#string

Coles EK

http://www.w3.org/2001/XMLSchema#string

Fabiano GA

http://www.w3.org/2001/XMLSchema#string

Fielbelkorn K

http://www.w3.org/2001/XMLSchema#string

Forehand GL

http://www.w3.org/2001/XMLSchema#string

Gnagy EM

http://www.w3.org/2001/XMLSchema#string

Hoffman MT

http://www.w3.org/2001/XMLSchema#string

Lock TM

http://www.w3.org/2001/XMLSchema#string

Meichenbaum DL

http://www.w3.org/2001/XMLSchema#string

P304

E105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.107.6.E105

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235352758

http://www.w3.org/2001/XMLSchema#string

P698

11389303

http://www.w3.org/2001/XMLSchema#string